Brookdale Shares Down 4.9% Despite Q1 Earnings Meeting Estimates

Brookdale Senior Living (BKD) shares fell 4.9% despite Q1 2025 earnings meeting expectations with a loss of $0.11 per share, though revenue of $813.9 million missed estimates by 0.8%. While resident fees and occupancy rates improved, the results were weighed down by rising facility operating expenses and administrative costs, leading to a wider net loss of $65 million. However, management raised its full-year RevPAR growth outlook to 5%-5.75% and adjusted EBITDA to $440-$450 million, projecting positive adjusted free cash flow of $30-$50 million for 2025.

Analysis

Brookdale Senior Living (BKD) shares declined 4.9% following its Q1 2025 earnings release, where a loss per share of $0.11 met consensus estimates and was narrower than the prior-year quarter's $0.13 loss. The negative market reaction appears driven by total revenues of $813.9 million, which, while up 4% year-over-year, missed analyst expectations by 0.8%, and a significant widening of the net loss to $65 million from $29.6 million a year ago. This increased net loss was attributed to higher facility operating expenses (up 2.7% Y/Y to $557 million due to wage and utility inflation), increased general and administrative costs (up 4.7% Y/Y), and a 23.7% decrease in interest income. However, underlying operational metrics showed improvement: resident fees grew 4.5% Y/Y to $777.5 million, driven by a 3% rise in RevPOR and a 140 basis point increase in weighted average occupancy to 79.3%. Consequently, RevPAR increased 4.9% Y/Y, and adjusted EBITDA saw a robust 27.2% year-over-year growth to $124.1 million. The company also reported a positive shift in cash flow, generating $23.4 million in net cash from operations compared to a $1.1 million use in the prior year, and an adjusted free cash inflow of $3.8 million versus an outflow of $26.3 million. Despite these operational gains, BKD's balance sheet showed a decline in cash to $239.7 million and an increase in long-term debt to $4.2 billion. Looking ahead, management provided an optimistic outlook, raising its full-year 2025 RevPAR growth guidance to 5%-5.75% and adjusted EBITDA guidance to $440-$450 million, while projecting positive adjusted free cash flow between $30-$50 million.

Key Decisions for Investors

• Investors should closely monitor Brookdale's ability to manage escalating facility operating and administrative costs, as these are currently offsetting revenue growth and operational improvements, impacting net profitability.
• The raised full-year guidance for RevPAR, adjusted EBITDA, and particularly the projection for positive adjusted free cash flow, presents a potential upside, making the achievement of these targets critical indicators for future stock performance.
• Given the mixed Q1 results, including the revenue miss and wider net loss despite underlying operational gains, and the subsequent share price decline, a cautious approach is warranted; consistent improvements in cost control and sustained occupancy and RevPAR growth will be key to rebuilding investor confidence.